The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin
Year: 2007
Type: article
Study design: Clinical Trial
Authors: Y.-L. He, R. Sabo, J. Campestrini, Y. Wang, M. Ligueros-Saylan, K. C. Lasseter, S. C. Dilzer, D. Howard, W. P. Dole
Institutions: Novartis (France), Zoo Miami
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2042457844